Leaderboard

En | De
Sie sind hier: Respirationstrakt » Neoplasie 18. September 2026
Suchen
medline.ch
Neoplasie
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Allergische Rhinitis - Pollinosis
Asthma
Bronchitis
COPD
Interstitielle Pneumopathien
Lungenembolie
Neoplasie
Pleuraerkrankungen
Pneumonie
SARS
Schlaf- Apnoe-Syndrom
Tuberkulose
Zystische Fibrose
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 8158  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 163146  
   
Navigation Bronchoscopy Specific Cone-Beam CT Software Enabling Pre- And Intraprocedural Guidance: A Prospective Clinical Feasibility Study.
J Bronchology Interv Pulmonol
Wijma IN, van der Sterren W, Verhoeven RLJ, van der Heijden EHFM.
PMID: 42755268 [PubMed - indexed for MEDLINE]


American Association of Bronchology and Interventional Pulmonology Essential Knowledge in Interventional Pulmonology Series: Advanced Diagnostic Bronchoscopy in Lung Cancer: Closing the Diagnostic Gap and Beyond.
J Bronchology Interv Pulmonol
Channick CL, Ali MS, Benenson DM, Bhadra K, Phan AT, Schwalk AJ, Wong C, Chrissian AA.
PMID: 42755264 [PubMed - indexed for MEDLINE]


Feature Copy-Paste with Fine-Grained Data Augmentation for Robust Lung Cancer Analysis in CT Images.
J Imaging Inform Med
Huang X, Liu C, Sang H, Wu Y, Wang C, Tian J, Wang S.
PMID: 42754740 [PubMed - as supplied by publisher]


An adjacent-frame Siamese U-Net for markerless angle-agnostic lung tumor tracking from projections in radiotherapy.
Phys Med
Ye Q, Zhang X, Tan X, Wei W, Wu Y, Duan L, Li J, Guo H, Shi J, Yu H, Xia Y, Bai S, Li G.
PMID: 42753627 [PubMed - as supplied by publisher]


Navigating tarlatamab and bispecific T-cell engager therapy in small cell lung cancer: A narrative review.
Cancer Treat Res Commun
Abdalla BA.
PMID: 42753581 [PubMed - as supplied by publisher]


A Multicenter Randomized Phase III Trial Comparing MET Tyrosine Kinase Inhibitors vs. Immune Checkpoint Inhibitors With or Without Chemotherapy as First-Line Treatment for Patients With Advanced Non-Small Cell Lung Cancer Harboring MET Exon 14 Skipping Mutations: JCOG2506 (DECIDE-MET).
Clin Lung Cancer
Mitome N, Kunimasa K, Nomura S, Kawabata K, Masuda K, Shiraishi Y, Kenmotsu H, Ando M, Fukuda H, Okamoto I, Goto Y, Lung Cancer Study Group of the Japan Clinical Oncology Group.
PMID: 42753422 [PubMed - as supplied by publisher]


Role of CYP3A4 in the metabolism of tyrosine kinase inhibitors in non-small cell lung cancer therapy.
Drug Metab Dispos
Sultana S, Kamal MS, Chen H, Li W.
PMID: 42753302 [PubMed - as supplied by publisher]


Longitudinal Clinical, Physiological, and Molecular Profiling of Female Patients With Metastatic Cancer: Protocol and Feasibility of a Multicenter High-Definition Oncology Study.
JCO Precis Oncol
Garma LD, Pernas S, Vicente Baz D, García Campelo R, Terrasa J, Nasarre B, Vera García R, Bermejo B, González Santiago S, Fullana B, Rodríguez-Pérez M, Fernandez Bruno M, Reboredo Rendo C, Perelló A, Jiménez D, Guerra JA, Arrazubi V, de la Cruz S, Cejalvo JM, Tebar C, Núñez Berrueco E, Hernández-Marín B, Rogado J, Olmos PM, Arbaizar LP, Villalba Oliva MA, Madrid Y, Sanz-Landaluze J, Moreno-Martín G, Morillas A, Lopez-Alonso A, Rodríguez-Patón A, Colomer R, Artés-Rodríguez A, Quintela-Fandino M.
PMID: 42753220 [PubMed - indexed for MEDLINE]


Main pulmonary artery enlargement during bevacizumab therapy in KRAS-mutant metastatic colon cancer.
Cancer Chemother Pharmacol
Ozbay MF, Atl, Vurgun S, Hunur M, Keven A, Sahin E, Göksu SS, Karaca M.
PMID: 42752894 [PubMed - indexed for MEDLINE]


Evaluation of MET Detection Methods and Cutoffs in EGFR-Mutated Non-small Cell Lung Cancer Following Disease Progression on Osimertinib in the phase II SAVANNAH study.
Clin Cancer Res
Ahn MJ, de Marinis F, Cho BC, Kim TM, Cheng S, Novello S, Proto C, Kim SW, Lee JS, Metro G, Sequist LV, Yang JC, Xu W, Telaranta-Keerie A, Todd A, D'Angelo G, Hartmaier R, Bonanno L.
PMID: 42752799 [PubMed - as supplied by publisher]


Molecules of lung cancer - fusion alterations in nonsmall cell lung cancer: biology and diagnostic considerations.
Breathe (Sheff)
Talty M, O'Reilly D, Dunne J, Naidoo J.
PMID: 42751219 [PubMed]


Individualized approach to palliative care integration for patients with metastatic non-small cell lung cancer.
Front Med (Lausanne)
Mitchell C, Kailar RS, Hsu ML.
PMID: 42750937 [PubMed]


Beyond tobacco: understanding the growing burden of lung adenocarcinoma in women.
Oncol Rev
Virata MCA, Abello RMR, Brillante EMB, Interior JS, Relacion PR, Molen RGC, Alea EPM, Mojica JCP.
PMID: 42750867 [PubMed]


ALPHA-1 antitrypsin genotype, sex, and lung cancer: Clinical and molecular characterisation.
Pulmonology
García-Rodríguez E, Tubío-Pérez RA, Candal-Pereira C, Villar-Aguilar L, Priegue-Carrera A, Fernández-Villar A, Ruano-Raviña A, Torres-Durán M.
PMID: 42750455 [PubMed - indexed for MEDLINE]


Salvage R0 Resection on Post-Recurrence Survival After Pulmonary Metastasectomy for Colorectal Cancer: A Multicenter Retrospective Study.
Ann Surg Oncol
Hashimoto S, Tominaga T, Shiraishi T, Noda K, Yamashita M, Katayama H, Takamura Y, Mizoguchi S, Obata T, Taniguchi D, Doi R, Shimoyama K, Miyazaki T, Hisanaga M, Ishii M, Ono R, Nakatsukasa T, Kamohara R, Araki M, Sumida Y, Nakamura A, Nonaka T, Matsumoto K.
PMID: 42749975 [PubMed - as supplied by publisher]


mRNA-based therapeutics in lung Cancer: Mechanisms, applications, and translational challenges.
J Genet Eng Biotechnol
Wehbe I, Tlili A.
PMID: 42749398 [PubMed]


National trends, variation and short-term outcomes in surgery for non-small cell lung cancer in England, 2015-2023: a population-based cohort study using linked national cancer registration and hospital administrative data.
BMJ Open
Dixon LK, Cook S, Cook A, Thomas J, Boudour J, Chan F, Conibear J, West D, Navani N, Cromwell DA.
PMID: 42749376 [PubMed - indexed for MEDLINE]


Targeting EGFR-Mutant Non-Small Cell Lung Cancer in Asia: An Update on Monotherapy and Combination Therapy With EGFR Inhibitors.
Respirology
Sunaga N, Hasegawa Y, Sato M.
PMID: 42749289 [PubMed - as supplied by publisher]


Final Biomarker and Efficacy Analyses of Lorlatinib in Patients With ALK-Positive Advanced Non-Small Cell Lung Cancer in a Phase 2 Study.
J Thorac Oncol
Bauer TM, Martini JF, Besse B, Lin CC, Soo RA, Riely GJ, Wang IM, Toffalorio F, Shepard DA, Usari T, Hamilton P, Camidge DR, Kao S, Chiari R, Gadgeel S, Felip E, Shaw AT, Solomon BJ.
PMID: 42749050 [PubMed - as supplied by publisher]


Defining Early Recurrence in Resectable Non-small Cell Lung Cancer Using Post-Recurrence Survival.
Lung
Naeem W, Khan AA, Rabin EE, Broad S, Denson KL, Casanova T, Basu S, Alex G, Geissen N, Liptay MJ, Seder CW.
PMID: 42747627 [PubMed - indexed for MEDLINE]


   
   Artikel 1 - 20 / 163146    Seite 1 von 8158  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

  Zeitfenster  
   

Sky right 1